Sector: Pharmaceuticals & Biotechnology

Small Cap

Ind-Swift Laboratories Share Price

Ind-Swift Laboratories Ltd.

₹156.40

-1.60(-1.01%)

Trade Now

8th Jun 2026 | 3:28 PM

NSE : INDSWFTLAB

Open Free Demat Account

Ind-Swift Laboratories Performance

Price Movement

₹156.40

₹154.20

₹162.36

↘ Today's Low↗ Today's High

1 Year Performance

₹156.40

₹87.15

₹173.25

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹162.36

Low₹154.20

Open at₹155.11

Prev Close₹158.00

Volumes8.49 L

Avg Price₹159.27

Lower Circuit₹126.40

Upper Circuit₹189.60

Historical Performance

3M High₹173.25

3M Low₹127.30

1 Yr High₹173.25

1 Yr Low₹87.15

3 Yr High₹186.00

3 Yr Low₹68.50

5 Yr High₹186.00

5 Yr Low₹52.65

Summary

As of 08-06-2026 19:53, Ind-Swift Laboratories Ltd. share price today is ₹0, with a change of ₹-158.00 (-100.00%) from the previous close of ₹158. The stock opened at ₹155.11 and traded between ₹154.2 and ₹162.36, with a total traded volume of 848615 shares. The company has a market capitalization of ₹1363 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹173.25 and ₹87.15, respectively.

Ind-Swift Laboratories Ltd. valuation metrics include a P/E ratio of 32.9, EPS of ₹4.95, and book value of ₹1.00. Profitability indicators show ROE of 2.99%. Ind-Swift Laboratories Ltd. has reported revenue of ₹626.02 Cr and net profit of ₹41.42 Cr.

Ind-Swift Laboratories Ltd. technical indicators include Day RSI at 62.75, Day MFI at 82.95, Day ADX at 21.59. Additional indicators include Commodity Channel Index (CCI) at 90.7 and Williams %R at -37.74. Momentum indicators show Day MACD at 5.43, Day MACD Signal Line at 3.22, DayATR at 8.3. Rate of Change indicators for Ind-Swift Laboratories Ltd. include ROC125 at 64.02 and ROC21 at 12.16.

Exponential moving averages include EMA5 at ₹156.3, EMA10 at ₹152.3, EMA12 at ₹150.9, EMA20 at ₹147.1, EMA26 at ₹145.4, EMA50 at ₹141.2, EMA100 at ₹133.4, EMA200 at ₹123. Simple moving averages include SMA5 at ₹158.1, SMA10 at ₹151, SMA20 at ₹143.2, SMA30 at ₹141.6, SMA50 at ₹140.9, SMA100 at ₹134, SMA150 at ₹121.4, SMA200 at ₹116.6.

Support levels for Ind-Swift Laboratories are placed at First Support ₹153.17, Second Support ₹149.61, Third Support ₹145.01. Resistance levels are seen at First Resistance ₹161.33, Second Resistance ₹165.93, Third Resistance ₹169.49. Ind-Swift Laboratories Ltd. shareholding pattern shows promoter holding at 42.99%, FII holding at 13.88%, DII holding at 0%, public holding at 43.14%.

Ind-Swift Laboratories Fundamentals

Market Cap

Above industry Median

1,363 Cr.

PE Ratio (TTM)

Above industry Median

32.90

Dividend Yield

Net Profit TTM

81% decr over last year

41.42

Net Profit Growth

81% decr over last year

41.42

PEG Ratio

Negative PEG TTM

-0.40

ROE

86% decr over last year

2.99

Operating Revenue TTM

626.02

Operating Revenue Growth

226.0% incr over last year

Book Value

Low in industry

MFI

MFI strongly Overbought

82.95

RSI

RSI is mid-range

62.75

EPS (TTM)

4.95

Debt to Equity

0.01

Face Value

Operating Profit Margin Qtr.

6.55

Operating Profit Qtr.

20.57

Net Profit Qtr.

15.11

Operating Revenue Qtr.

169.79

PB Ratio

Ind-Swift Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	172.70	149.48	150.44	147.99	144.75
Operating Expense	152.40	144.08	148.25	144.92	158.21
Operating Profit	20.30	5.40	2.19	3.07	-13.47
Depreciation	8.08	8.84	6.98	6.68	7.44
Interest	-2.44	0.67	2.01	1.15	-26.76
Tax	-3.22	6.87	2.30	1.71	8.06
Net Profit	14.94	10.74	8.76	8.12	218.09

Ind-Swift Laboratories Technicals

Ind-Swift Laboratories Ltd. EMA & SMA

₹156.40

-1.60 (-1.01%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹156.3

Day EMA10 ₹152.3

Day EMA12 ₹150.9

Day EMA20 ₹147.1

Day EMA26 ₹145.4

Day EMA50 ₹141.2

Day EMA100 ₹133.4

Day EMA200 ₹123

Ind-Swift Laboratories Support and Resistance

Resistance

First Resistance₹161.33

Second Resistance₹165.93

Third Resistance₹169.49

Support

First Support₹153.17

Second Support₹149.61

Third Support₹145.01

Technical Indicators

Day RSI62.75

Day MFI82.95

Day ADX21.59

Day Commodity Channel Index90.70

William-37.74

Day MACD5.43

Day MACD Signal Line3.22

Day ATR8.30

Day ROC12564.02

Day ROC2112.16

Ind-Swift Laboratories Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	42	40.9	40.9	39.5	39.5	43
FII	0.5	3.1	4.3	14.8	14.3	13.9
DII	0.9	0.9	0.9	0.7	0.7	0
Public	56.6	55.1	53.9	45	45.5	43.1

Ind-Swift Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	5.29 L	13.38 L	39.52%
Week	8.06 L	23.19 L	34.76%
1 Month	5.1 L	12.81 L	39.84%
6 Month	3.99 L	9.63 L	41.45%

Ind-Swift Laboratories SWOT Analysis

Strengths23

Weakness9

Opportunity0

Threats0

Promoter holding increased more than 2% QoQ

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Stringent DVM Screener

Weekly Screener: High Momentum Score Stocks (subscription)

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing profits every quarter for the past 2 quarters

Companies with Zero Promoter Pledge

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Ind-Swift Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Instrument Type
20 Sep, 2011	1	FINAL	Equity Share
16 Sep, 2010	1	FINAL	Equity Share
17 Sep, 2009	1	FINAL	Equity Share
18 Sep, 2008	1	FINAL	Equity Share
21 Sep, 2007	1	FINAL	Equity Share
22 Sep, 2006	1.5	FINAL	Equity Share
22 Sep, 2005	1.5	FINAL	Equity Share
23 Sep, 2004	1	FINAL	Equity Share

Ind-Swift Laboratories Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.
Price (₹)	₹126	₹550.90	₹6.14	₹108	₹131.65	₹14.15
% Change	N/A	1.05%	-3.91%	-3.57%	-1.38%	1.22%
Revenue TTM (₹ Cr)	-	-	₹83.60	-	₹287.68	₹176.50
Net Profit TTM (₹ Cr)	-	-	₹-34.95	-	₹14.88	₹27.81
PE TTM	61.50	-	-1.50	12.90	34.20	26.90
1 Year Return	-7.48	40.54	523	-14.06	3.85	54.51
ROCE	-	3.56	-5.63	-	-	17.36

Similar Stocks

MEDISTEP

Medistep Healthcare Ltd.

₹ 19.55

+0.00%

INFLUX

Influx Healthtech Ltd.

₹ 233.00

-2.51%

MOREPENLAB

Morepen Laboratories Ltd.

₹ 42.52

-2.81%

LYKALABS

Lyka Labs Ltd.

₹ 63.60

+0.05%

ACCPL

Accretion Pharmaceuticals Ltd.

₹ 137.70

-4.97%

SATKARTAR

Sat Kartar Life Ltd.

₹ 166.00

-0.98%

ONYX

Onyx Biotec Ltd.

₹ 42.00

+0.00%

VAISHALI

Vaishali Pharma Ltd.

₹ 7.30

+0.27%

BALAXI

Balaxi Pharmaceuticals Ltd.

₹ 24.50

+0.91%

QUESTLAB

Quest Laboratories Ltd.

₹ 100.50

-1.47%

ZENITHDRUG

Zenith Drugs Ltd.

₹ 42.95

+5.79%

ACCENTMIC

Accent Microcell Ltd.

₹ 474.10

-0.69%

SUNREST

Sunrest Lifescience Ltd.

₹ 34.00

+0.00%

MONOPHARMA

Mono Pharmacare Ltd.

₹ 11.80

+3.06%

REMUS

Remus Pharmaceuticals Ltd.

₹ 713.00

+1.39%

INFINIUM

Infinium Pharmachem Ltd.

₹ 199.05

-4.07%

JFLLIFE

JFL Life Sciences Ltd.

₹ 9.50

-5.00%

WALPAR

Walpar Nutritions Ltd.

₹ 25.75

-4.98%

ZOTA

Zota Healthcare Ltd.

₹ 1202.50

-4.54%

BETA

Beta Drugs Ltd.

₹ 1404.60

-4.23%

PAR

Par Drugs & Chemicals Ltd.

₹ 85.00

-5.44%

SAKAR

Sakar Healthcare Ltd.

₹ 761.00

-1.58%

MEDIORG

Medicamen Organics Ltd.

₹ 21.00

+0.00%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 552.20

+0.03%

FAQ's on INDSWFTLAB

What is the current share price of Ind-Swift Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Ind-Swift Laboratories Ltd. is ₹ 156.4 on the NSE and ₹ 156.1 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Ind-Swift Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Ind-Swift Laboratories Ltd. is approximately ₹ 1363 Cr.

What are the PE and PB ratios for Ind-Swift Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Ind-Swift Laboratories Ltd. is 32.9, and the Price-to-Book (PB) ratio is 1.

What is the 52-Week High and Low for Ind-Swift Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Ind-Swift Laboratories Ltd. shares was ₹ 173.25, and the lowest price was ₹ 87.15.

Who are the major shareholders of Ind-Swift Laboratories Ltd.?

Significant shareholdings in Ind-Swift Laboratories Ltd. typically include entities such as:

Public
Promoter
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Ind-Swift Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Ind-Swift Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Ind-Swift Laboratories Ltd.?

Ind-Swift Laboratories Ltd. last declared a FINAL dividend of ₹ 1 per share for the financial period ending 2011. The record date was set as 2011-09-20, and the payment was/is scheduled around 2011-09-20. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy